Amylyx to release Phase 3 LUCIDITY trial topline results for avexitide in post-bariatric hypoglycemia Aug. 18, 2026
AMLX•Phase 3 LUCIDITY topline results due Aug. 18
Amylyx scheduled topline Phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia on Aug. 18, 2026.
Results have not been presented yet; management plans an 8:00 a.m. ET conference call with an audio webcast.
The update is expected to clarify whether avexitide can meaningfully reduce hypoglycemia episodes in this patient group.
